Can you help us to provide evidence of the patient experience of treatments in CLL and specifically, of this treatment for a UK NICE technology appraisal in the near future.
CLL Support and working with Leukaemia Care and Lymphoma Action to support this treatment as an option for CLL patients.
The first section of this survey is directed to all CLL patients, and we would like to collect as many responses as possible. The second section involves questions specifically for CLL patients who have taken ibrutinib with venetoclax (as a combination) as their FIRST treatment. You will be redirected to the end of the survey if this is not relevant to you.
Thank you
You can find the survey here
Jackie